Home
Bios Equity Partners II, 10% Owner: Lantern Pharma LTRN Sell · Filed 25/05/29
Trade details
- Type
- Insider sale
- Amount
- $22,807.9
- Shares · price
- 7,478 sh · $3.05 a share
- Held after
- 421,808 sh
- Stock
- Lantern Pharma LTRN
- Trade date
- 25/05/27
- Filed
- 25/05/29
- Days to filing
- 2 days
Sold 1.7% of holdings
- Share of holding sold
- 1.7%
Lantern Pharma trades, last 26 weeks
What else happened in Lantern Pharma around then
Filed or reported within 30 days of the trade day · 25/04/27~25/06/26Bios Equity Partners II's recent trades
- Bios Equity Partners II
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$43.9K
14,218 sh
$43.9K
Filed 25/06/13
Traded 25/06/13
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$38.1K
12,319 sh
$38.1K
Filed 25/06/13
Traded 25/06/13
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$22.3K
7,206 sh
$22.3K
Filed 25/06/13
Traded 25/06/13
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$13.5K
4,354 sh
$13.5K
Filed 25/06/13
Traded 25/06/13
